News Conference News ACC 2025 Cardiologists Plot Next Moves After New Board Rejected Yael L. Maxwell April 11, 2025
News Conference News ACC 2025 EARLY TAVR: Delaying Valve Replacement Increases Risk of Poor Outcomes L.A. McKeown April 07, 2025
News Conference News ACC 2025 FAIR-HF2: Another IV Iron Trial Fails to Impact Hard Endpoints L.A. McKeown April 03, 2025
News Conference News ACC 2025 Tight Fluid Restriction Not Needed in Chronic HF Patients: FRESH-UP Michael O'Riordan April 01, 2025
News Conference News ACC 2025 Shelf-stable Product May Sub in for Frozen Plasma in Cardiac Surgery: FARES-II L.A. McKeown March 31, 2025
News Conference News ACC 2025 By 2 Years, Tricuspid TEER Reduces Hospitalizations for HF: TRILUMINATE Michael O'Riordan March 31, 2025
News Conference News ACC 2025 Dapagliflozin Works Well for High-Risk TAVI Patients With HF: DapaTAVI Caitlin E. Cox March 30, 2025
Presentation ACC 2025 The MIGHTy-Heart Randomized Clinical Trial Presenter: Ruth Masterson Creber March 30, 2025
Presentation ACC 2025 FAIR-HF2 Trial: Intravenous iron in patients with systolic heart failure and iron deficiency to improve morbidity & mortality Presenter: Stefan D. Anker March 30, 2025
Presentation ACC 2025 Liberal Fluid Intake versus Fluid Restriction in Chronic Heart Failure: The FRESH-UP Study Presenter: Roland R. Van Kimmenade March 30, 2025
News Conference News ACC 2025 SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes Michael O'Riordan March 29, 2025
Presentation ACC 2025 Dapagliflozin after Transcatheter Aortic Valve Implantation Presenter: Sergio Raposeiras-Roubin March 29, 2025
News Daily News ACC 2025 STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients L.A. McKeown March 29, 2025
News Conference News ACC 2025 WARRIOR: No Clear Answers on How to Best Treat INOCA Yael L. Maxwell March 29, 2025
News Opinion Editor's Corner ACC 2025 What’s Going to Be Hot at ACC 2025? Michael O'Riordan March 26, 2025